Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort
Description
High rates of lung failure have been reported in haematological patients after SARS-CoV2 infection. An early administration of monoclonal antibodies or anti-virals may improve the prognosis. Oral anti-virals may have a wider use independently of the
